Astec LifeSciences Limited reported unaudited standalone and consolidated earnings results for the third quarter and nine months ended December 31, 2016. For the quarter, on standalone basis, the company reported total income from operations of INR 623.792 million compared to INR 320.276 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 97.107 million compared to loss from operations before other income, finance costs and exceptional items of INR 73.716 million a year ago. Profit from ordinary activities before tax was INR 44.534 million compared to loss from ordinary activities before tax of INR 109.468 million a year ago. Net profit for the period was INR 7.006 million or INR 0.36 per diluted share before and after extraordinary items compared to net loss for the period of INR 78.526 million or INR 4.03 per diluted share before and after extraordinary items a year ago. For the nine months, on standalone basis, the company reported total income from operations of INR 2,223.001 million compared to INR 1,527.354 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 1,851.586 million compared to INR 1,435.187 million a year ago. Profit from ordinary activities before tax was INR 244.767 million compared to loss from ordinary activities before tax of INR 23.265 million a year ago. Net profit for the period was INR 156.020 million or INR 7.99 per diluted share before and after extraordinary items compared to net loss for the period of INR 5.335 million or INR 0.27 per diluted share before and after extraordinary items a year ago. For the quarter, on consolidated basis, the company reported total income from operations of INR 623.850 million compared to INR 320.275 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 97.314 million compared to loss from operations before other income, finance costs and exceptional items of INR 73.566 million a year ago. Profit from ordinary activities before tax was INR 44.697 million compared to loss from ordinary activities before tax of INR 109.317 million a year ago. Net profit after taxes, minority interest and share of profit of associates was INR 7.081 million or INR 0.36 per diluted share before and after extraordinary items compared to net loss after taxes, minority interest and share of loss of associates of INR 78.458 million or INR 4.02 per diluted share before and after extraordinary items a year ago. For the nine months, on consolidated basis, the company reported total income from operations of INR 2,229.010 million compared to INR 1,634.079 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 1,856.303 million compared to INR 1,435.187 million a year ago. Profit from ordinary activities before tax was INR 246.176 million compared to loss from ordinary activities before tax of INR 23.545 million a year ago. Net profit after taxes, minority interest and share of profit of associates was INR 156.572 million or INR 8.01 per diluted share before and after extraordinary items compared to net loss after taxes, minority interest and share of loss of associates of INR 6.397 million or INR 0.33 per diluted share before and after extraordinary items a year ago.